Ir para o conteúdo principal
S23 - CLINICAL CASE Toxins - New label & off-label
domingo 11 julho 2021
16:00 para 17:30
Channel 1
ESTUDO DE CASO CLÍNICO
Em colaboração com ISDS

Presidente (s) da sessão

Dr. Kate GOLDIE
Dr. Kate GOLDIE
Médico
Reino Unido
Dr. Malavika KOHLI
Dr. Malavika KOHLI
Dermatologista
Índia
Dr. Atchima SUWANCHINDA
Dr. Atchima SUWANCHINDA
Dermatologista
Tailândia
Prof. Wenyu WU
Prof. Wenyu WU
Dermatologista
China

Parceiro da sessão

International Society for Dermatologic Surgery
International Society for Dermatologic Surgery
https://www.isdsinternational.org/ info@isdsworld.com

Palestras da sessão

16:00

avatar_chairs Dr. Atchima SUWANCHINDA
Welcome message from ISDS

16:02

avatar_chairs Dr. Benjamin ASCHER
Current new toxins: where are we

16:12

avatar_chairs Prof. Rungsima WANITPHAKDEEDECHA
Botulinum toxin antibody : what we have known so far

16:22

avatar_chairs Prof. Wayne CAREY
Should we always aim to raise the eyebrow with botulinum toxin?

16:32

avatar_chairs Dr. Pin Chi CHIU
Microdroplets of botulinum toxin for cutaneous neurovascular modulation

16:42

avatar_chairs Dr. Niamh CORDUFF
Applying dynamic facial anatomy during neuromodulator treatments for ‘natural’ outcomes

16:52

avatar_chairs Dr. Cheng Kun WANG
Complications and anatomy of toxin injection in facial aesthetics

17:02

avatar_chairs Dr. Vasanop VACHIRAMON
Protective effect of INCO against ultraviolet-induced hyperpigmentation: a randomized controlled trial (unrestricted educational grant from Merz Aesthetics)

17:12

Discussion of difficult cases

17:22

Discussion and Q&A with the audience

17:30

Sessões recomendadas

Tem uma pergunta?

Processando, aguarde...

Erro

Por favor, preencha todos os campos necessários. Aqui estão os campos que estão faltando: